ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

29,076Medicare Part D Prescriptions Filled, Including Refills

Rank: 12 out of 2343

$1.12M Total Retail Price of All Prescriptions

Rank: 85 out of 2343

803 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
58% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 803 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

11% of this provider’s 803 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 25,823 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$38 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
FUROSEMIDE 1,229 1,084 1 6
SIMVASTATIN 1,168 1,012 2 1
LISINOPRIL 1,137 988 3 3
LEVOTHYROXINE SODIUM 957 860 4 2
ATENOLOL 815 740 5 12
OMEPRAZOLE 756 633 6 4
HYDROCODONE-ACETAMINOPHEN 706 576 S3 7 13
METOPROLOL TARTRATE 666 628 8 7
METFORMIN HCL 606 501 9 9
WARFARIN SODIUM 543 465 10 8
AMLODIPINE BESYLATE 542 507 11 5
ATORVASTATIN CALCIUM 509 473 12 10
POTASSIUM CHLORIDE 494 454 13 18
METOPROLOL SUCCINATE 458 409 14 14
CITALOPRAM HBR 458 418 14 17
GABAPENTIN 440 386 16 16
TRAMADOL HCL 418 362 17 25
DONEPEZIL HCL 381 380 18 21
RANITIDINE HCL 352 327 19 43
KLOR-CON M20 321 307 20 44
ALENDRONATE SODIUM 311 283 21 28
TRAZODONE HCL 292 253 22 53
CRESTOR 286 225 23 30
ALLOPURINOL 275 239 24 31
PREDNISONE 274 258 25 37
HALOPERIDOL 270 270 26 229
NAMENDA 265 265 27 36
MIRTAZAPINE 254 254 28 41
VENLAFAXINE HCL ER 244 226 29 87
ISOSORBIDE MONONITRATE ER 237 214 30 32
IPRATROPIUM-ALBUTEROL 236 225 31 99
RISPERIDONE 232 220 32 61
HYDROCHLOROTHIAZIDE 224 192 33 11
QUETIAPINE FUMARATE 224 207 33 77
FAMOTIDINE 224 163 33 60
GLIPIZIDE XL 222 201 36 84
TRIAMTERENE-HCTZ 208 187 37 57
OXYCODONE-ACETAMINOPHEN 208 205 S2 37 49
GLIPIZIDE 207 185 39 56
DIGOXIN 196 179 40 35
PANTOPRAZOLE SODIUM 191 183 41 22
CLOPIDOGREL 187 164 42 26
TRIAMCINOLONE ACETONIDE 175 171 43 137
CARBIDOPA-LEVODOPA 172 168 44 85
LOSARTAN POTASSIUM 161 148 45 19
SERTRALINE HCL 158 128 46 20
NOVOLIN 70-30 157 125 47 268
PAROXETINE HCL 149 137 48 66
CLONIDINE HCL 148 140 49 70
FENTANYL 136 134 S2 50 69
TAMSULOSIN HCL 136 125 50 29
AMOX TR-POTASSIUM CLAVULANATE 131 114 52 160
ZOLPIDEM TARTRATE 129 106 53 24
SULFAMETHOXAZOLE-TRIMETHOPRIM 128 122 54 120
LEVOFLOXACIN 125 112 55 106
PLAVIX 125 108 55 38
MORPHINE SULFATE ER 125 115 S2 55 142
VENTOLIN HFA 124 102 58 79
ADVAIR DISKUS 123 118 59 34
LIPITOR 117 112 60 78
CARVEDILOL 116 100 61 27
CELEBREX 111 110 62 71
SEROQUEL 109 101 63 171
FLUTICASONE PROPIONATE 107 85 64 46
AMITRIPTYLINE HCL 106 95 R 65 117
KLOR-CON 10 104 83 66 134
FINASTERIDE 96 96 67 80
SPIRONOLACTONE 95 95 68 65
ESCITALOPRAM OXALATE 93 93 69 55
CYMBALTA 92 80 70 74
DIVALPROEX SODIUM 91 91 71 105
PRAVASTATIN SODIUM 90 89 72 15
CEPHALEXIN 89 86 73 111
INSULIN SYRINGE 88 69 74 102
COMBIVENT 86 68 75 144
HYDRALAZINE HCL 86 86 75 92
JANTOVEN 82 73 77 81
OXYCODONE HCL 81 55 S2 78 67
NITROSTAT 81 70 78 164
DIOVAN 80 68 80 23
NEXIUM 80 68 80 33
AMLODIPINE BESYLATE-BENAZEPRIL 80 80 80 59
FELODIPINE ER 80 80 80 116
NITROGLYCERIN PATCH 77 77 84 147
ACTOS 74 26 85 125
CIPROFLOXACIN HCL 72 67 86 72
LEVETIRACETAM 72 72 86 104
DOXAZOSIN MESYLATE 72 68 86 98
TERAZOSIN HCL 70 68 89 143
LANTUS 70 70 89 51
SPIRIVA 68 56 91 48
ESTRADIOL 67 61 R 92 524
PHENYTOIN SODIUM EXTENDED 67 43 92 152
HYDROXYZINE HCL 67 60 R 92 265
LYRICA 66 48 95 135
DILTIAZEM 24HR ER 65 56 96 76
ROPINIROLE HCL 65 61 96 124
GLIPIZIDE ER 64 61 98 115
DILTIAZEM 24HR CD 62 53 99 83
BACLOFEN 61 61 100 161
MELOXICAM 60 45 101 68
METOCLOPRAMIDE HCL 59 43 102 168
GLIMEPIRIDE 57 57 103 45
RIVASTIGMINE 57 57 103 395
CEFUROXIME 57 57 103 193
LOVASTATIN 56 56 106 47
PREMARIN 56 48 R 106 286
MECLIZINE HCL 54 42 108 103
AMOXICILLIN 54 43 108 118
LISINOPRIL-HYDROCHLOROTHIAZIDE 54 54 108 42
DOXYCYCLINE HYCLATE 53 43 111 180
ZETIA 53 53 111 52
PROAIR HFA 52 30 113 86
NITROFURANTOIN 51 51 114 330
JANUVIA 50 35 115 50
NORTRIPTYLINE HCL 50 50 115 239
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.